| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.513 | 31.821 | 52.910 | 28.705 | 11.293 | 132.574 | 129.587 | 126.826 | 130.737 | 128.527 |
| Total Income - EUR | 6.513 | 31.821 | 100.513 | 58.575 | 11.293 | 132.581 | 129.769 | 126.826 | 161.062 | 128.527 |
| Total Expenses - EUR | 45.584 | 71.779 | 112.638 | 39.226 | 12.321 | 15.730 | 117.535 | 68.232 | 110.305 | 109.568 |
| Gross Profit/Loss - EUR | -39.071 | -39.958 | -12.125 | 19.349 | -1.028 | 116.850 | 12.235 | 58.594 | 50.757 | 18.959 |
| Net Profit/Loss - EUR | -39.266 | -41.091 | -15.225 | 17.592 | -1.380 | 115.555 | 10.939 | 57.351 | 49.178 | 16.280 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Alba Iulimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 134.354 | 199.803 | 118.162 | 91.869 | 86.747 | 81.822 | 76.915 | 73.747 | 72.227 | 75.410 |
| Current Assets | 33.940 | 38.307 | 39.661 | 36.604 | 18.960 | 8.085 | 3.262 | 59.975 | 16.543 | 10.714 |
| Inventories | 15.818 | 491 | 7.730 | 7.972 | 376 | 3.585 | 1.150 | 0 | 0 | 0 |
| Receivables | 17.669 | 37.752 | 31.865 | 28.315 | 17.796 | 0 | 253 | 40.190 | 6.065 | 0 |
| Cash | 453 | 64 | 65 | 317 | 788 | 4.500 | 1.859 | 19.785 | 10.478 | 10.714 |
| Shareholders Funds | -56.618 | -97.132 | -110.714 | -91.089 | -90.705 | 26.570 | 36.919 | 67.454 | 82.425 | 49.341 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 224.912 | 335.242 | 268.537 | 219.562 | 196.411 | 63.337 | 43.257 | 73.365 | 3.009 | 21.605 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.411 | 15.178 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4531 - 4531" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Alba Iulimed S.r.l.